- Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem. Barron’s
- Hims & Hers stock slides 5% after second quarter revenue misses forecasts Yahoo Finance
- Hims & Hers stock falls 10% on revenue miss CNBC
- Investing in the Future of Healthcare Hims & Hers Newsroom
- IBD 50’s Hims Dives. Why It Will Remain A ‘Market Darling.’ Investor’s Business Daily
Source link
